Stetz Gary S.
- SEC CIK
- 0001532793
In the past year, 2 open-market purchase filings worth $150.0K and 1 sale filing worth $343.9K.
Current role at each company
- HEPA Hepion Pharmaceuticals, Inc.Interim CEOas of Aug 21, 2026
- CNTN Canton Strategic Holdings, Inc.Directoras of May 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $150.0K
- 2 filings
- Sold
- $343.9K
- 1 filing
- Net
- −$193.9K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Stetz Gary S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HEPA Hepion Pharmaceuticals, Inc.
Interim CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 (view filing)9:41 PM ET | Aug 3 | 9 daysLate | Stetz Gary S.Interim CEO | PPurchase | +2.00M | $0.05 | +$100.0K | +160.0%3.25M after | |
| Aug 12, 2026 (view filing)9:41 PM ET | Aug 3 | 9 daysLate | Stetz Gary S.Interim CEO | PPurchase | +2.00M | $0.00 | $0 | –2.00M after | Derivative |
| Apr 27, 2026 (view filing)6:24 AM ET | Apr 21 | 6 daysLate | Stetz Gary S.Interim CEO | PPurchaseCommon Stock, par value $0.0001 per share | +1.25M | $0.04 | +$50.0K | New position1.25M after |
CNTN Canton Strategic Holdings, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 (view filing) | May 22-26 | 5 days | Stetz Gary S.Director | SSale | −100.4K | $3.43 | −$343.9K | −42.8%134.2K after | 8 lots |